Andrea Bartzen

Founder

Impactiv BioConsult

Andrea Bartzen is a strategic commercial/communication consultant that partners with New York City investment teams looking to fund innovative biotech, life science and health tech companies. As a multidisciplinary strategic commercial pre-launch and launch expert, she has had successful results with the strategic planning, implementation and team leadership for some of the largest and influential pharmaceutical brand launches in the last 10 years. Through promo med ed, HCP promotion, market access and PR channels, she has directed full life-cycle development, from early commercial, medical need/disease-shaping at phase 2 (Ilaris), brand development (Keytruda), franchise positioning (BMS PD1) and post-LOE strategy (Lipitor). Bartzen has also helped develop breakthrough medical communication platforms in each category: Keytruda (Immuno-oncology/PD1 inhibitor); Pradaxa (stroke); Lipitor (cardiovascular) Atripla (HIV); Botox, Vimpat (CNS), as well as successfully developed education and communication strategies that shift KOL and specialists' mindsets, leading to the transformation of medical paradigms and treatment norms.